FDA approves smaller paclitaxel-coated balloon for PAD

The FDA approved a paclitaxel-coated balloon catheter to treat peripheral artery disease in the superficial femoral and popliteal arteries that is compatible with 0.018" guidewires, Medtronic announced.
The IN.PACT 018 Paclitaxel-Coated Percutaneous Transluminal Angioplasty (PTA) Balloon Catheter uses the same drug coating formulation and is built upon equivalent technology to the IN.PACT Admiral DCB, which is compatible with 0.035” guidewires, according to Medtronic. The IN.PACT 018 DCB is indicated for PTA of de novo, restenotic or in-stent restenotic lesions with lengths up to 360 mm

The FDA approved a paclitaxel-coated balloon catheter to treat peripheral artery disease in the superficial femoral and popliteal arteries that is compatible with 0.018″ guidewires, Medtronic announced.
The IN.PACT 018 Paclitaxel-Coated Percutaneous Transluminal Angioplasty (PTA) Balloon Catheter uses the same drug coating formulation and is built upon equivalent technology to the IN.PACT Admiral DCB, which is compatible with 0.035” guidewires, according to Medtronic. The IN.PACT 018 DCB is indicated for PTA of de novo, restenotic or in-stent restenotic lesions with lengths up to 360 mm